10 results
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
#INR #heparin #LMWH ... #NOAC #warfarin ... apixaban #Eliquis #dabigatran
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Reversal Agents - Warfarin ... Kcentra) - Heparin/LMWH ... Protamine sulfate - Dabigatran ... anticoagulation #doac ... #noac #pharmacology
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Weight Heparin (LMWH ... Enoxaparin - Warfarin ... ) inhibitors - Dabigatran ... #medications #doac
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Anticoagulants - Pathophysiology ... anticoagulant (e.g. warfarin ... #Pharmacology #Pathophysiology ... #UFH #DOAC #Dabigatran ... #Fondaparinux #NOAC
Effect of Anticoagulants on Coagulation Tests
PT / INR, aPTT, Anti-Xa Activity, Activated Clotting Time, Thrombin Time,
Clotting Time Warfarin ... UFH LMWH Fondaparinux ... Argatroban Dabigatran ... Anticoagulation #Testing #Diagnosis
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
For patients on warfarin ... interruption per treatment ... of Therapy • Dabigatran ... postoperative #DOAC ... Perioperative #Management #Treatment
The coagulation cascade is shown, separated into different phases with their endogenous and pharmacological inhibitors shown.
clot #PT #PTT #diagnosis ... models #hematology #pathophysiology ... anticoagulant #Warfarin ... #Dabigatran #thrombin
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook

Presentation: 
 • Plts ↓50% (nadir
Thrombocytopenia (HIT) - Diagnosis ... ♀, ↑Age, ESRD Pathophysiology ... ), reverse any warfarin ... , Bivalirudin, DOAC ... #Management #Treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Pathophysiology ... opacities • Diagnosis ... Renal Failure Treatment ... Noah Rosenberg @
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... /MRA • Avoid Warfarin ... and DOAC • Planning ... Cardiomyopathy #diagnosis ... management #cardiology #treatment